Billionaire Profile
Joseph Edelman
Global Rank
#1512

Image: Bchelnit | CC0 | via Wikimedia Commons

Joseph Edelman

CEO, Hedge funds
UNITED STATES
Real-Time Net Worth
$2.749B
Estimated based on Hedge funds stock value as of March 6, 2026
0% (24h)
Age
70
Source
Hedge funds
Industry
Finance & Investments
Citizenship
UNITED STATES

Biography

Joseph Edelman is a prominent American hedge fund manager, best known for founding Perceptive Advisors, a New York City-based firm specializing in biotechnology investments. Born in 1955, Edelman has built an impressive career over several decades. His wealth stems from his expertise in hedge funds. Edelman's career began as a biotechnology analyst before he founded Perceptive Advisors in 1999. The firm's focus on biotechnology and healthcare has led to significant returns for investors. Edelman's deep understanding of the life sciences and his strategic investments have helped him achieve a high net worth and significant achievements within the financial industry.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life and Education

Joseph Edelman was born in 1955. He grew up in San Francisco and is the son of Isidore Edelman, a renowned scientist and professor emeritus of biochemistry and molecular biophysics at Columbia's College of Physicians and Surgeons. Edelman earned a Bachelor of Arts degree in Psychology, graduating magna cum laude from the University of California, San Diego, in 1978. He then pursued a Master of Business Administration from New York University's Stern School of Business in 1988.

Rise to Success

Edelman began his career in 1987 as a biotechnology analyst at Labe, Simpson & Company. He subsequently worked as a senior biotech analyst at Prudential Securities and later at Paramount Capital Asset Management for a biotech hedge fund called Aries. In 1999, he founded Perceptive Advisors, a hedge fund firm specializing in biotechnology stocks. The firm's assets grew to $10 billion by July 2023, showcasing Edelman's success in the financial world.

Key Business Strategies

Perceptive Advisors focuses on identifying and investing in promising technologies and innovations in biotechnology. Edelman's approach involves a deep understanding of scientific expertise combined with bold and patient capital. The firm's investment strategy is rooted in understanding the 'perception' of corporate events in the biotech sector and then investing in 'reality' after conducting in-depth research. The firm utilizes careful risk management to mitigate the volatility around biotech stocks.

Philanthropy

Edelman established the Edelman Family Foundation. The foundation supports various organizations and causes. The foundation primarily funds Do No Harm, an advocacy group that opposes anti-racism education in public schools and gender-affirming care for minors. Other recipients of Foundation funds include the Cato Institute, the Foundation Against Intolerance and Racism, and the Manhattan Institute.

Career Milestones

1987

Biotechnology Analyst

Began his career as a biotechnology analyst.

1990

Senior Biotech Analyst

Worked as a senior biotech analyst at Prudential Securities.

1999

Founder of Perceptive Advisors

Founded Perceptive Advisors, a hedge fund firm focused on biotechnology investments.

2018

Joined the Three-Comma Club

Joined the three-comma club with a $1.1 billion net worth.

2022

SEC Settlement

Perceptive Advisors settled charges with the U.S. Securities and Exchange Commission (SEC).

2024

Resigned from Brown University Board

Resigned from the Brown University board of trustees due to the upcoming vote on Israel divestment.

Philanthropy & Social Impact

Philanthropy

Edelman Family Foundation

Unknown

Supports various organizations, including Do No Harm, Cato Institute, and Foundation Against Intolerance and Racism.

Controversies & Challenges

2022

SEC Charges

Perceptive Advisors settled charges with the U.S. Securities and Exchange Commission (SEC) for failing to disclose that the firm's employees had stakes in the SPACs the investors were directed to.

2024

Resignation from Brown University Board

Resigned from the Brown University Board of Trustees in protest of a vote regarding divestment from companies linked to Israel.